These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10610354)

  • 21. Absence of functional mutations in the ferroportin-encoding SLC40A1 gene in porphyria cutanea tarda: a series of 37 cases from southern France.
    Du Thanh A; Martinez P; Cunat S; Bessis D; Guillot B; Dereure O
    Acta Derm Venereol; 2011 Jun; 91(4):467. PubMed ID: 21607294
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
    Frank J; Poblete-Gutiérrez P; Weiskirchen R; Gressner O; Merk HF; Lammert F
    Physiol Res; 2006; 55 Suppl 2():S75-83. PubMed ID: 17298224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
    Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O
    Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic hemochromatosis and the HFE gene: from molecular genetics to clinical diagnosis].
    Höhler T; Gerken G
    Z Gastroenterol; 2000 Jun; 38(6):509-15. PubMed ID: 10923364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent.
    Hift RJ; Corrigall AV; Hancock V; Kannemeyer J; Kirsch RE; Meissner PN
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):853-9. PubMed ID: 12699243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [59-year-old patient with cutaneous lesions and increased iron metabolism parameters].
    Mangold E; Diepolder H; Lohse P; Pape GR; Ritter MM
    Internist (Berl); 2000 Oct; 41(10):1103-7. PubMed ID: 11084896
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
    Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron status and HFE mutations in first-degree relatives of patients with sporadic porphyria cutanea tarda, in a Mediterranean area.
    Garcia-Morillo JS; Lorca RR; Bernabeu-Wittel M; Garcia-Junco PS; Andreu EP; de la Fuente JC
    J Intern Med; 2005 Apr; 257(4):389-90; author reply 391-3. PubMed ID: 15788010
    [No Abstract]   [Full Text] [Related]  

  • 29. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
    Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
    An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron overload in porphyria cutanea tarda.
    Sampietro M; Fiorelli G; Fargion S
    Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature.
    Young LC
    Cutis; 2007 Nov; 80(5):415-8. PubMed ID: 18189029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of an unusual combination of mutations in the HFE gene for hemochromatosis.
    Thorstensen K; Asberg A; Kvitland M; Svaasand E; Hveem K; Bjerve KS
    Genet Test; 2000; 4(4):371-6. PubMed ID: 11216661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
    Brady JJ; Jackson HA; Roberts AG; Morgan RR; Whatley SD; Rowlands GL; Darby C; Shudell E; Watson R; Paiker J; Worwood MW; Elder GH
    J Invest Dermatol; 2000 Nov; 115(5):868-74. PubMed ID: 11069625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation analysis of the HLA-H gene in French hemochromatosis patients, and genetic counseling in families.
    Mercier G; Burckel A; Bathelier C; Boillat E; Lucotte G
    Genet Couns; 1998; 9(3):181-6. PubMed ID: 9777338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Porphyria cutanea tarda with sclerodermatous changes and hemochromatosis].
    Wallaeys E; Thierling U; Lang E; Neumann NJ; Frank J
    Hautarzt; 2014 Apr; 65(4):272-4. PubMed ID: 24718503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HFE gene mutations in patients with rheumatoid arthritis.
    Li J; Zhu Y; Singal DP
    J Rheumatol; 2000 Sep; 27(9):2074-7. PubMed ID: 10990216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Porphyria cutanea tarda. An analysis of HFE gene mutations, hepatitis viruses, alcohol intake, and other risk factors in 54 patients from Guipúzcoa, Basque Country, Spain].
    Castiella A; Zapata E; de Juan MD; Múgica F; Barrio J; Otazua P; Arriola JA; Cosme A; Elosegui E; Fernández J; Zubiaurre L; Alzate LF; Utrilla E;
    Rev Esp Enferm Dig; 2008 Dec; 100(12):774-8. PubMed ID: 19222337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients.
    Cruz-Rojo J; Fontanellas A; Morán-Jiménez MJ; Navarro-Ordóñez S; García-Bravo M; Méndez M; Muñoz-Rivero MC; de Salamanca RE
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):845-52. PubMed ID: 12699242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Are the hemochromatosis (HFE) gene mutation and hepatitis C virus (HCV) infection risk factors for porphyria cutanea tarda?].
    Nagy Z; Kószó F; Pár A; Nagy A; Horányi M; Morvay M; Dobozy A; Mózsik G
    Orv Hetil; 2000 Sep; 141(37):2031-4. PubMed ID: 11037612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.